News

The Centricity Practice Solution 11 solution, which features a dynamic search engine, simplifies the data entry required for ambulatory practices to comply with new the ICD-10 coding requirements

Various studies demonstrated a woman’s ability to recognize OAB symptoms, understand vital safety information on the label, judge the necessity of the product use and fittingly use Oxytrol

European patent covers a chemical structure and new chemical process of the chemistry platform technology, developed for therapeutic and cosmetic purpose. Sirona Biochem chief executive officer Neil Belenkie

Desloratadine ODT is a generic equivalent to Clarinex Reditabs (desloratadine), which according to IMS Health data had total sales of $5.3m in the US for the twelve months

Takeda expects to launch the type 2 diabetes therapies as adjuncts to diet and exercise in the summer of 2013. Takeda Pharmaceuticals USA president Douglas Cole said, "Takeda

The single dose Pneumococcal 13-valent conjugate vaccine [Diphtheria CRM197 Protein] will provide protection from invasive disease caused by 13 Streptococcus pneumoniae serotypes. Pfizer vaccine president Susan Silbermann said,

The CE-marked solution enables clinicians to plan and perform high-dose-rate (HDR) brachytherapy treatments for prostate cancer using real-time ultrasound guidance. The treatment involves delivery of radiotherapy from inside

The commencement of the study trigered a $30m milestone payment to Threshold Pharmaceuticals from Merck under a license and co-development agreement signed between the companies. Randomized, placebo-controlled Phase

In the double-blind study, 845 patients were administered with Folfox or Folfiri and bevacizumab as the front-line treatment of locally-advanced or metastatic colorectal cancer. Neulasta demonstrated the significant